Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial

Peer Review reports

Original Submission
18 Apr 2021	Submitted	Original manuscript
9 Oct 2021	Reviewed	Reviewer Report - Riaz Qureshi
29 Nov 2021	Author responded	Author comments - Timothy Jackson
Resubmission - Version 2
29 Nov 2021	Submitted	Manuscript version 2
6 Dec 2021	Reviewed	Reviewer Report - Riaz Qureshi
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
23 Dec 2021	Editorially accepted
31 Jan 2022	Article published	10.1186/s13063-021-05966-3

Back to article page